ARIAD to Present at the Cowen and Company 34th Annual Health Care Conference Date : 02/24/2014 @ 7:35AM Source : Business Wire Stock : Ariad Pharmaceuticals, Inc. (MM) (ARIA) Quote : 8.87 0.14 (1.60%) @ 7:24AM
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Cowen and Company 34th Annual Health Care Conference being held in Boston. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company’s business on Tuesday, March 4, at 10:40 a.m. (ET). The ARIAD presentation will be webcast live and can be accessed by visiting the investor relations section of the Company's website at http://www.ariad.com/investor. A replay of the presentation will also be available and archived on the site for three weeks.
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. For additional information, visit http://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm).
ARIAD Pharmaceuticals, Inc. For Investors Kendra Adams, 617-503-7028 Kendra.adams@ariad.com or For Media Liza Heapes, 617-621-2315 Liza.heapes@ariad.com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.